Tweenvest Stocks

Neurizon Therapeutics Limited (ASX: NUZ)

Health Care · Pharmaceuticals · AU

AU$0.09

+4.88% today · -25.2% 1Y

Neurizon Therapeutics Limited (ASX: NUZ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $46.88M and employs 36 people.

Over the last twelve months the share price has lost 25.2%, trading between 0.05 and 0.13.

Tweenvest scores Neurizon Therapeutics Limited across four factors: quality 52/100, value 60/100. Its strongest factor is value.

NUZ price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$46.88M
Revenue (TTM)
$12.17M
P/E
—
EPS
-0.02
Dividend yield
—
Beta (5Y)
1.16
52-week high
AU$0.13
52-week low
AU$0.05
Avg volume (3M)
—
Shares outstanding
775.10M
Employees
36
Next earnings
—

About Neurizon Therapeutics Limited

Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.

ISIN
AU0000357261
Founded
2000
Listed since
Oct 4, 2001
Exchange
Australian Securities Exchange
Currency
AUD
CompanyMarket capPriceDay
Sunny Pharmtech Inc.TPEX: 6676$48.98MNT$9.42-5.52%
Tien Liang BioTech Co., Ltd.TPEX: 4127$48.87MNT$34.85-8.17%
AB Science S.A.ENXTPA: AB$48.33M€0.54-1.46%
Albert David LimitedBSE: 524075$48.25MRs794.80+4.18%
PharmGen Science, Inc.KOSE: A004720$46.88M₩2,765.00-0.36%
Ildong Holdings Co., Ltd.KOSE: A000230$46.76M₩5,480.00-3.18%
Labiana Health, S.A.BME: LAB$46.73M€5.05-0.98%
Infinium Pharmachem LimitedNSEI: INFINIUM$46.28MRs279.15-0.66%

Browse every Pharmaceuticals company →

Figures last refreshed Nov 8, 2026.